Unlike standard GH injections Ipamorelin and its peptides mimic the bodys natural GH pulses
The problem for professional bodies such as the American Association of Clinical Endocrinology, which issue clinical guidelines, is that evidence microdosing works is largely anecdotalthough a paper published in April suggests responses to the drugs do vary with an individuals genes
This formulation combines Tesamorelin, a synthetic analog of growth hormonereleasing hormone (GHRH), and Ipamorelin, a selective growth hormone secretagogue, both of which are commonly examined in laboratory environments for their influence on endocrine signaling pathways related to growth hormone regulation
Obesity rates have almost tripled since 1975, which researchers say is due to a combination of factors, including: Increased access to energy-dense food coupled with reduced physical activity Sleep deprivation Circadian desynchronization Chronic stress A rise in the use of certain medications known to result in weight gain, including some anti-epileptic and psychotropic drugs Other genetic and environmental factors As a result, prescription drug companies have sought their own way to target the treatment of obesity